T3011 Clinical Trials
3 recruitingBiologic
Phase 23Phase 12
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Clinical Study of T3011 in Subjects With Advanced Melanoma
Advanced Melanoma
Shanghai Pharmaceuticals Holding Co., Ltd42 enrolled7 locationsNCT06214156
Recruiting
Phase 1Phase 2
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
SarcomaMelanomaNSCLC+3 more
ImmVira Pharma Co. Ltd30 enrolled9 locationsNCT04370587
Recruiting
Phase 2
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Nonmuscle-invasive Bladder Cancer
ImmVira Pharma Co. Ltd160 enrolled2 locationsNCT06971614